A Study to Evaluate Gemcitabine Plus Cisplatin in the Treatment of TNBC Patients Following Neoadjuvant Chemotherapy
Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
This is a prospective, open-lable phase II clinical trial evaluating the effectiveness and
safety of gemcitabine plus cisplatin as adjuvant treatment for non-pCR TNBC patients after
standard neoadjuvant chemotherapy.